Chifeng Passes FDA Inspection

Chifeng Passes FDA Inspection

CHIFENG CITY, Inner Mongolia--ChifengPharmaceutical announced it underwent--and passed--a facilities inspection bythree Food and Drug Administration (FDA) officials from Oct. 2 to 8 at itsephedra manufacturing facility here. According to the company, this was thefirst ephedra manufacturing facility tour for the FDA officials, who evaluatedevery detail of the manufacturing process, from raw materials to packaging andstorage of the final product. Chifeng Pharmaceutical, which has a U.S. office inRaleigh, N.C., announced it demonstrated appropriate cGMPs (current goodmanufacturing practices), including a validated process and analytical methods,in addition to appropriate systems for producing ephedra extract powder. Thecompany also noted it demonstrated that all of its extract comes from natural mahuang grass extraction.